Medindia

X

Osteotech Announces First Quarter Earnings Release and Conference Call Schedule

Friday, April 18, 2008 General News J E 4
Advertisement
EATONTOWN, N.J., April 17 Osteotech, Inc.(Nasdaq: OSTE) announced today that the Company's first quarter ended March31, 2008 financial results will be released Thursday, May 1, 2008. Aconference call will be conducted by Sam Owusu-Akyaw, President and ChiefExecutive Officer, as well as other members of Osteotech management, onThursday, May 1, 2008, at 9:00 a.m. Eastern time. You are invited to listen tothe conference call by dialing 1-706-643-1624. Automated playback will beavailable two hours after completion of the live call through midnight,Thursday, May 15, 2008 by dialing 1-706-645-9291 and indicating access code43861543.

A live, listen-only webcast of our conference call will also be availableat our investor site at http://www.osteotech.com on the Financial Highlightspage. A replay of the conference call and the question/answer session will beavailable at the Company's website for approximately 14 days following thecall. It will be necessary to have RealPlayer installed on your computer.

Osteotech, Inc., headquartered in Eatontown, New Jersey, is a globalleader in providing OsteoBiologic solutions for regenerative medicine tosupport surgeons and their patients in the repair of the musculoskeletalsystem through the development of innovative therapy-driven products thatalleviate pain, promote biologic healing and restore function. For furtherinformation regarding Osteotech, this press release or the conference call,please go to Osteotech's website at http://www.osteotech.com.

SOURCE Osteotech, Inc.
Advertisement


Advertisement

You May Also Like

Advertisement
View All

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
User Avatar
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions
s
Squire Sanders Stands Out in Independent Analysis ...
S
Genomics Likely to Replace Traditional Drug Therap...